Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion

• Jonathan Zalevsky,
• Deborah H Charych,
• Alfredo Nicosia,
• Fulvia Troise,
• Anna Morena D'Alise,
• Guido Leoni,
• Maria De Lucia,
• Francesca Langone,
• Linda Nocchi,
• Fabio Giovanni Tucci,
• Elisa Micarelli,
• Gabriella Cotugno,
• Irene Garzia,
• Rosa Vitale,
• Veronica Bignone,
• Elena Di Matteo,
• Rosa Bartolomeo,
• Armin Lahm,
• Elisa Scarselli

Affiliations

Jonathan Zalevsky

Nektar Therapeutics, San Francisco, California, USA

Deborah H Charych

Nektar Therapeutics, San Francisco, California, USA

Alfredo Nicosia

NousCom, Rome, Italy

Fulvia Troise

NousCom, Rome, Italy

Anna Morena D'Alise

NousCom, Rome, Italy

Guido Leoni

NousCom, Rome, Italy

Maria De Lucia

NousCom, Rome, Italy

Francesca Langone

NousCom, Rome, Italy

Linda Nocchi

NousCom, Rome, Italy

Fabio Giovanni Tucci

NousCom, Rome, Italy

Elisa Micarelli

NousCom, Rome, Italy

Gabriella Cotugno

NousCom, Rome, Italy

Irene Garzia

NousCom, Rome, Italy

Rosa Vitale

NousCom, Rome, Italy

Veronica Bignone

NousCom, Rome, Italy

Elena Di Matteo

NousCom, Rome, Italy

Rosa Bartolomeo

NousCom, Rome, Italy

Armin Lahm

NousCom, Rome, Italy

Elisa Scarselli

NousCom, Rome, Italy